Lipoxins as biomarkers of lupus and other inflammatory conditions

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Das, Undurti N ^a,b,c,d  

^a UND LIFE SCIENCES   (United States)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^c KRISHNA INSTITUTE OF MEDICAL SCIENCES   (India)

^d GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

Author keywords

autoimmunity; cytokines; diabetes mellitus; free radicals; lipoxins; Lupus; maresins; multiple sclerosis; prostaglandins; protectins; resolvins; rheumatoid arthritis; tumor necrosis factor

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; G PROTEIN COUPLED RECEPTOR; ICOSAPENTAENOIC ACID; INDOMETACIN; INTERLEUKIN 10; INTERLEUKIN 4; LINOLEIC ACID; LINOLENIC ACID; LIPID; LIPOXIN; LIPOXIN A; MARESIN; NITROLIPID; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; PARACETAMOL; POLYUNSATURATED FATTY ACID; RESOLVIN; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CYTOKINE; FATTY ACID; LEUKOTRIENE;

ANAPHYLACTOID PURPURA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; DISEASE COURSE; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LUPUS ERYTHEMATOSUS NEPHRITIS; METABOLISM; MULTIPLE SCLEROSIS; NONHUMAN; PROGNOSIS; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT RESPONSE; URINE LEVEL; ANIMAL; BIOLOGICAL MODEL; GLOMERULUS; NEPHRITIS; PATHOLOGY; URINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CYTOKINES; FATTY ACIDS; HUMANS; INFLAMMATION; KIDNEY GLOMERULUS; LEUKOTRIENES; LIPOXINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, BIOLOGICAL; NEPHRITIS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 79955866041     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-76     Document Type: Article

References (48)

1. Clinical laboratory tools to diagnose inflammation. UN Das, Advances in Clinical Chemistry 2006 41 189 229 (Pubitemid 43648627)
2. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. CN Serhan, Prostaglandins Leukot Essent Fatty Acids 2005 73 141 162 10.1016/j.plefa.2005. 05.002 16005201 (Pubitemid 41253472)
3. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. J Claria CN Serhan, Proc Natl Acad Sci USA 1995 92 9475 9479 10.1073/pnas.92.21.9475 7568157
4. Essential fatty acids: Biochemistry, physiology, and pathology. UN Das, Biotechnology J 2006 1 420 439 10.1002/biot.200600012
5. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammatory signals. CN Serhan S Hong K Gronert SP Colgan PR Devchand G Mirick R-L Moussignac, J Exp Med 2002 196 1025 1037 10.1084/jem.20020760 12391014 (Pubitemid 35231761)
6. Essential fatty acids- a review. UN Das, Current Pharmaceutical Biotechnol 2006 7 467 482 10.2174/138920106779116856 (Pubitemid 46017539)
7. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. N Chiang M Arita CN Serhan, Prostaglandins Leukot Essen Fatty Acids 2005 73 163 177 10.1016/j.plefa.2005.05.003 (Pubitemid 41253473)
8. Lipid mediator class switching during acute inflammation signals in resolution. BD Levy CB Clish B Schmidt K Gronert CN Serhan, Nat Immunol 2001 2 612 619 10.1038/89759 11429545 (Pubitemid 32677628)
9. 4stable analogs that block transmigration and adhesion of human neutrophils. CN Serhan JF Maddox NA Petasis I Akritopoulou-Zanze A Papayianni HR Brady SP Colgan JL Madara, Biochemistry 1995 34 14609 14615 10.1021/bi00044a041 7578068 (Pubitemid 3000720)
10. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. BN Zordoky AO El-Kadi, Pharmacol Ther 2010 125 446 463 10.1016/j.pharmthera.2009.12.002 20093140
11. Review article: epoxyeicosatrienoic acids: novel mediators of cardioprotection. K Nithipatikom GJ Gross, J Cardiovasc Pharmacol Ther 2010 15 112 119 10.1177/1074248409358408 20200327
12. Epoxyeicosatrienoic acids and endothelium-dependent responses. WB Campbell I Fleming, Pflugers Arch 2010 459 881 895 10.1007/s00424-010-0804-6 20224870
13. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. C Arnold A Konkel R Fischer WH Schunck, Pharmacol Rep 2010 62 536 547 20631419
14. Cytochrome P450 pathways of arachidonic acid metabolism. DL Kroetz DC Zeldin, Curr Opin Lipidol 2002 13 273 283 10.1097/00041433-200206000-00007 12045397 (Pubitemid 34592284)
15. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. L Gao H Yin GL Milne NA Porter JD Morrow, J Biol Chem 2006 281 14092 14099 10.1074/jbc.M601035200 16569632 (Pubitemid 43848336)
16. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. CN Serhan CB Clish J Brannon SP Colgan N Chiang K Gronert, J Exp Med 2000 192 1197 1204 10.1084/jem.192.8.1197 11034610
17. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions. CN Serhan CB Clish J Brannon SP Colgan K Gronert N Chiang, J Physiol Pharmacol 2000 51 4 Pt 1 643 654 11192938 (Pubitemid 32049518)
18. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. VL Marcheselli S Hong WJ Lukiw XH Tian K Gronet A Musto M Hardy JM Gimenez N Chiang CN Serhan NG Bazan, J Biol Chem 2003 278 43807 43817 10.1074/jbc.M305841200 12923200 (Pubitemid 37346009)
19. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. S Hong K Gronert PR Devchand RL Moussignac CN Serhan, J Biol Chem 2003 278 14677 14687 10.1074/jbc.M300218200 12590139 (Pubitemid 36799790)
20. Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. M Romano G Luciotti S Gangemi F Marinucci C Prontera E D'Urbano G Dav Lab Invest 2002 82 1253 1254 12218086 (Pubitemid 35014859)
21. Physical exercise increases urinary excretion of lipoxin A4 and related compounds. S Gangemi G Luciotti E D'Urbano A Mallamace D Santoro G Bellinghieri G Davi M Romano, J Appl Physiol 2003 94 2237 2240 12588790 (Pubitemid 36605283)
22. Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. S Gangemi L Pescara E D'Urbano G Basile V Nicita-Mauro G Dav M Romano, Exp Gerontol 2005 40 612 614 10.1016/j.exger.2005.04.004 15935589 (Pubitemid 41074808)
23. Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch-Schönlein purpura. SH Wu PY Liao PL Yin YM Zhang L Dong, Prostaglandins Leukot Essent Fatty Acids 2009 80 177 183 10.1016/j.plefa.2009. 01.008 19264468
24. Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. T Katoh FG Lakkis N Makita KF Badr, Kidney Int 1994 46 341 349 10.1038/ki.1994.280 7967345
25. Role of leukotrienes and lipoxygenases in glomerular injury. GM Nassar KF Badr, Miner Electrolyte Metab 1995 21 262 270 7565475
26. Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. A Papayianni CN Serhan ML Phillips HG Rennke HR Brady, Kidney Int 1995 47 1295 1302 10.1038/ki.1995.184 7543622
27. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. YM O'Meara HR Brady, Kidney Int Suppl 1997 58 56 S61 9067945
28. Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. SH Wu PY Liao PL Yin YM Zhang L Dong, Am J Pathol 2009 174 115 122 10.2353/ajpath.2009.080671 19095947
29. Expression analysis of G Protein-Coupled Receptors in mouse macrophages. JE Lattin K Schroder AI Su JR Walker J Zhang T Wiltshire K Saijo CK Glass DA Hume S Kellie MJ Sweet, Immunome Res 2008 4 5 10.1186/1745-7580-4-5 18442421
30. G protein-coupled receptors for free fatty acids. G Milligan LA Stoddart AJ Brown, Cell Signal 2006 18 1360 1365 10.1016/j.cellsig.2006.03.011 16716567 (Pubitemid 43842097)
31. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. DY Oh S Talukdar EJ Bae T Imamura H Morinaga W Fan P Li WJ Lu SM Watkins JM Olefsky, Cell 2010 142 687 698 10.1016/j.cell.2010.07.041 20813258
32. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Y Suresh UN Das, Prostaglandins Leukotrienes Essential Fatty Acids 2001 64 37 52 10.1054/plef.2000.0236 (Pubitemid 32142555)
33. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: Effect of -6 fatty acids. Y Suresh UN Das, Nutrition 2003 19 93 114 10.1016/S0899-9007(02)00856-0 12591540 (Pubitemid 36194469)
34. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: Effect of -3 fatty acids. Y Suresh UN Das, Nutrition 2003 19 213 228 10.1016/S0899-9007(02)00855-9 12620523 (Pubitemid 36279459)
35. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. LC Stene G Joner Norwegian Childhood Diabetes Study Group, Am J Clin Nutr 2003 78 1128 1134 14668274 (Pubitemid 39663453)
36. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. LC Stene J Ulriksen P Magnus G Joner, Diabetologia 2000 43 1093 1098 10.1007/s001250051499 11043854
37. High Pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. J Bellenger S Bellenger A Bataille KA Massey A Nicolaou M Rialland C Tessier JX Kang M Narce, Diabetes
38. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. PJ White M Arita R Taguchi JX Kang A Marette, Diabetes 2010 59 3066 3073 10.2337/db10-0054 20841610
39. Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. UN Das LG Pusks, Lipids Health Dis 2009 8 61 10.1186/1476-511X-8-61 20042103
40. Phospholipase A2 and signal transduction. JV Bonventre, J Am Soc Nephrol 1992 3 128 150 1391715
41. Lipid mediator class switching during acute inflammation: signals in resolution. BD Levy CB Clish B Schmidt K Gronert CN Serhan, Nat Immunol 2001 2 612 619 10.1038/89759 11429545 (Pubitemid 32677628)
42. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. C Godson S Mitchell K Harvey NA Petasis N Hogg HR Brady, J Immunol 2000 164 1663 1667 10657608 (Pubitemid 30108713)
43. Inducible cyclooxygenase may have anti-inflammatory properties. DW Gilroy PR Colville-Nash D Willis J Chivers MJ Paul-Clark DA Willoughby, Nat Med 1999 5 698 701 10.1038/9550 10371510 (Pubitemid 29289435)
44. 2isoforms in the checkpoint control of acute inflammation. DW Gilroy J Newson P Sawmynaden DA Willoughby JD Croxtall, FASEB J 2004 18 489 498 10.1096/fj.03-0837com 15003994 (Pubitemid 38326305)
45. Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins. F Cominelli CC Nast R Llerena CA Dinarello RD Zipser, J Clin Invest 1990 85 582 586 10.1172/JCI114476 2298922 (Pubitemid 20070069)
46. Pro- and anti- inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. JH Schwab SK Anderle RR Brown FG Dalldorf RC Thompson, Infect Immun 1991 59 4436 4442 1834576
47. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. CN Serhan S Hong K Gronert SP Colgan PR Devchand G Mirick R-L Moussignac, J Exp Med 2002 196 1025 1037 10.1084/jem.20020760 12391014 (Pubitemid 35231761)
48. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein-dependent activation of cPLA2 activity. JD Croxtall Q Choudhury H Tokumoto RJ Flower, Biochem Pharmacol 1995 50 465 474 10.1016/0006-2952(95)00156-T 7646551